Study of KN026 Combined With KN046 in Patients With Locally Advanced HER2-positive Solid Tumors
Clinical trial NCT04521179 · COMPLETED
Trial details
- NCT number
- NCT04521179
- Sponsor
- Jiangsu Alphamab Biopharmaceuticals Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-07
- Primary completion
- 2022-01-12
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.